Related Experiment Video
Updated: May 25, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth
Gene L Bidwell1, Eddie Perkins2, Drazen Raucher1
1Department of Biochemistry, The University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA; Cancer Institute, The University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.
Abstract:
Although surgical resection with adjuvant chemotherapy and/or radiotherapy are used to treat breast tumors, normal tissue tolerance, development of metastases, and inherent tumor resistance to radiation or chemotherapy can hinder a successful outcome. We have developed a thermally responsive polypeptide, based on the sequence of Elastin-like polypeptide (ELP), that inhibits breast cancer cell proliferation by blocking the activity of the oncogenic protein c-Myc. Following systemic administration, the ELP - delivered c-Myc inhibitory peptide was targeted to tumors using focused hyperthermia, and significantly reduced tumor growth in an orthotopic mouse model of breast cancer. This work provides a new modality for targeted delivery of a specific oncogene inhibitory peptide, and this strategy may be expanded for delivery of other therapeutic peptides or small molecule drugs.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation
Inhibition of Cdk Activity
Inhibition of CDK Activity
Induced Pluripotent Stem Cells
Somatic cells are...
Mitogens and the Cell Cycle

